Medtronic denies wrongdoing after Infuse patient suffocates to death
This article was originally published in Clinica
Executive Summary
Medtronic has denied accusations that it encouraged the off-label use of its InFuse Bone Graft product to a physician who injected the product in a patient’s cervical spine, an action that led to fatal complications.